Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | RLAY | DFTX | ||
| Company | Enliven Therapeutics Inc | Relay Therapeutics Inc | Definium Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 45.01 | 15.99 | 24.80 | ||
| High | 45.72 | 16.40 | 25.25 | ||
| Low | 44.22 | 15.82 | 23.80 | ||
| Latest | 45.10 | 15.88 | 24.48 | ||
| Change | +0.24 | +0.32 | +0.05 | ||
| % Change | +0.53% | +2.06% | +0.20% | ||
| Volume | 2,449,800 | 10,738,900 | 2,629,800 | ||
| 20-Day Average Volume | 1,722,525 | 4,401,920 | 2,205,345 | ||
| Previous Close | 44.86 | 15.56 | 24.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.77 | 14.44 | 23.64 | ||
| 20-Day Raw Stochastic | 83.75% | 65.02% | 83.08% | ||
| 20-Day Relative Strength | 58.72 | 61.42 | 57.98 | ||
| Weighted Alpha | +36.77 | +337.78 | +239.53 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 56% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.74% since 06/11/26 | +11.52% since 06/11/26 | +1.53% since 06/11/26 | ||
| Low | 39.00 on 06/12/26 | 14.20 on 06/12/26 | 23.47 on 06/16/26 | ||
| High | 47.36 on 06/12/26 | 16.40 on 06/18/26 | 25.25 on 06/18/26 | ||
| 1-Month | |||||
| %Chg | +13.80% since 05/18/26 | +31.24% since 05/18/26 | +19.53% since 05/18/26 | ||
| Low | 33.45 on 06/08/26 | 11.62 on 05/20/26 | 19.33 on 05/19/26 | ||
| High | 47.36 on 06/12/26 | 17.47 on 06/02/26 | 25.25 on 06/18/26 | ||
| 3-Month | |||||
| %Chg | +65.50% since 03/18/26 | +59.92% since 03/18/26 | +38.78% since 03/18/26 | ||
| Low | 26.72 on 03/19/26 | 9.27 on 03/24/26 | 17.13 on 03/30/26 | ||
| High | 48.53 on 04/17/26 | 17.47 on 06/02/26 | 26.25 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | +170.38% since 12/18/25 | +95.33% since 12/18/25 | +95.22% since 12/18/25 | ||
| Low | 14.78 on 01/06/26 | 7.01 on 01/20/26 | 12.43 on 12/19/25 | ||
| High | 48.53 on 04/17/26 | 17.47 on 06/02/26 | 26.25 on 04/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,746,815 | 3,042,385 | 2,440,607 | ||
| Shares Outstanding, K | 60,905 | 191,586 | 99,698 | ||
| Annual Sales | 0 | 15,360,000 | 0 | ||
| Annual Net Income | -103,690,000 | -276,480,000 | -183,790,000 | ||
| Last Quarter Sales | 0 | 3,000,000 | 0 | ||
| Last Quarter Net Income | -23,630,000 | -73,290,000 | -77,100,000 | ||
| 60-Month Beta | 0.29 | 1.75 | 2.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 05/07/26 | -0.41 on 05/05/26 | -0.71 on 05/07/26 | ||
| Earnings Date | 08/12/26 | 08/06/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||